The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics

Figure 4

How dysbiosis alters bile acid metabolism, and resultant inflammation progressively leads to NAFLD (nonalcoholic fatty liver disease).